American Heart Journal
Volume 147, Issue 2 , Pages 202-209 , February 2004

Antibiotics for secondary prevention of coronary artery disease: an ACES hypothesis but we need to PROVE IT

  • Eli V Gelfand, MD

      Affiliations

    • Cardiovascular Division, Beth Israel Deaconess Medical Center, Boston, Mass, USA
    • Thrombolysis in Myocardial Infarction (TIMI) Study Group, Cardiovascular Division, Brigham and Women's Hospital, Boston, Mass, USA
    • ,
  • Christopher P Cannon, MD

      Affiliations

    • Thrombolysis in Myocardial Infarction (TIMI) Study Group, Cardiovascular Division, Brigham and Women's Hospital, Boston, Mass, USA
    • Corresponding Author InformationReprint requests: Christopher P. Cannon, MD, TIMI Study Group, Cardiovascular Division, Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02115, USA.

Received 13 June 2003 ,Accepted 5 September 2003.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0002-8703(03)00652-5

doi: 10.1016/j.ahj.2003.09.011

American Heart Journal
Volume 147, Issue 2 , Pages 202-209 , February 2004

Article Tools

* Image Usage & Resolution